From 29 to 31 May, the American Society of Clinical Oncology (ASCO) will hold its annual scientific meeting. This is the largest, and one of the most important, oncology meetings in the calendar year.
For the first time, ASCO20 will be held virtually adapting its programme and sessions to the COVID-19 situation. The programme will still feature over 250 oral abstract presentations and 2,500 poster presentations in 24 disease-based and speciality tracks. All presentations will be available on the ASCO20 website for a period of 180-days.
Myeloma Patients Europe (MPE) has identified the most important abstracts for myeloma and AL amyloidosis patients. If you are a myeloma patient advocate attending this congress virtually or interested in developments, please find in this document key myeloma and AL amyloidosis sessions that will be presented at ASCO20.
You can find information on how to register here.
You can see the ASCO20 virtual agenda and abstracts here.
If you are not registered to attend the conference, MPE will also be developing a webinar and publishing a Conference Report of ASCO20 and EHA highlights. Ensure you follow @MyelomaEurope and #ASCO20 on twitter and on Facebook to see up-to-date developments.